PD-L1 in tumor microenvironment mediates resistance to oncolytic immunotherapy (vol 128, pg 1413, 2018)

被引：24
|
作者：
Zamarin, Dmitriy
Ricca, Jacob M.
Sadekova, Svetlana
Oseledchyk, Anton
Yu, Ying
Blumenschein, Wendy M.
Wong, Jerelyn
Gigoux, Mathieu
Merghoub, Taha
Wolchok, Jedd D. [1 ,2 ,3 ,4 ,5 ,6 ,7 ,8 ,9 ,10 ,11 ,12 ,13 ,14 ,15 ,16 ,17 ,18 ,19 ,20 ,21 ,22 ,23 ,24 ,25 ,26 ,27 ]
机构：
[1] Adapt Biotechnol, Seattle, WA USA
[2] Advaxis, Princeton, NJ USA
[3] Amgen Inc, Thousand Oaks, CA USA
[4] Array BioPharma, Boulder, CO USA
[5] Ascentage Pharma, Rockville, MD USA
[6] BeiGene, Hong Kong, Hong Kong, Peoples R China
[7] Bristol Myers Squibb, New York, NY USA
[8] Celgene, Summit, NJ USA
[9] Chugai Pharmaceut Co Ltd, Tokyo, Japan
[10] Eli Lilly & Co, Indianapolis, IN 46285 USA
[11] F Star, Cambridge, England
[12] Genentech Inc, San Francisco, CA USA
[13] Kleo Pharmaceut, New Haven, CT USA
[14] MedImmune, Gaithersburg, MD USA
[15] Merck, Kenilworth, NJ USA
[16] Neon Therapuet, Cambridge, MA USA
[17] Ono Pharmaceut Co, Osaka, Japan
[18] Polaris Pharma, San Diego, CA USA
[19] Polynoma, San Diego, CA USA
[20] PsiOxus Therapeut, Abingdon, Oxon, England
[21] PureTech Hlth, Boston, MA USA
[22] Recepta Biopharma SA, Sao Paulo, Brazil
[23] Trieza Therapeut, Cambridge, MA USA
[24] Sellas Life Sci, New York, NY USA
[25] Serametrix Immune Monitoring, Carlsbad, CA USA
[26] Surface Oncol, Cambridge, MA USA
[27] Syndax, Waltham, MA USA
来源：
JOURNAL OF CLINICAL INVESTIGATION | 2018年 / 128卷 / 11期
关键词：
D O I：
10.1172/JCI125039
中图分类号：
R-3 [医学研究方法]; R3 [基础医学];
学科分类号：
1001 ;
摘要：
引用
收藏
页码：5184 / 5184
页数：1
相关论文
共 50 条
  • [41] The E3 ubiquitin ligases regulate PD-1/PD-L1 protein levels in tumor microenvironment to improve immunotherapy
    Hou, Bo
    Chen, Ting
    Zhang, He
    Li, Jiatong
    Wang, Peter
    Shang, Guanning
    FRONTIERS IN IMMUNOLOGY, 2023, 14
  • [42] Role of PD-L1 and Tumor Mutational Burden in NSCLC Immunotherapy
    Peters, S.
    JOURNAL OF THORACIC ONCOLOGY, 2021, 16 (03) : S74 - S74
  • [43] Remodeling of the tumor microenvironment using an engineered oncolytic vaccinia virus improves PD-L1 inhibition outcomes (vol 41, BSR20204186, 2021)
    不详
    BIOSCIENCE REPORTS, 2022, 42 (12)
  • [44] PD-1/PD-L1 Pathway Mediates the Alleviation of Pulmonary Fibrosis by Human Mesenchymal Stem Cells in Humanized Mice (vol 58, pg 684, 2018)
    Ni, K.
    Liu, M.
    Zheng, J.
    Wen, L.
    Chen, Q.
    Xiang, Z.
    Lam, K. T.
    Liu, Y.
    Chan, G. C. F.
    Lau, Y. L.
    Tu, W.
    AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY, 2021, 64 (01) : 150 - 151
  • [45] the importance of PD-L1 diagnostic assay harmonization for the selection of lung cancer immunotherapy (vol 10, pg S4096, 2018)
    Hernandez-Martinez, J. M.
    Zatarain-Barron, Z. L.
    Cardona, A. F.
    JOURNAL OF THORACIC DISEASE, 2019, 11 (03) : E64 - E64
  • [46] Oncolytic herpesvirus expressing PD-L1 BiTE for cancer therapy: exploiting tumor immune suppression as an opportunity for targeted immunotherapy
    Khalique, Hena
    Baugh, Richard
    Dyer, Arthur
    Scott, Eleanor M.
    Frost, Sally
    Larkin, Sarah
    Lei-Rossmann, Janet
    Seymour, Leonard W.
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2021, 9 (04)
  • [47] Targeting immune cell types of tumor microenvironment to overcome resistance to PD-1/PD-L1 blockade in lung cancer
    Wang, Man
    Zhu, Lijie
    Yang, Xiaoxu
    Li, Jiahui
    Liu, Yu'e
    Tang, Ying
    FRONTIERS IN PHARMACOLOGY, 2023, 14
  • [48] Association of tumor response to PD-1/PD-L1 immunotherapy and type of dermatitis that arises after the immunotherapy
    Lee, C.
    Li, S.
    Tran, D.
    Zhu, A.
    Kim, J.
    Kwong, B.
    Chang, A.
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2018, 138 (05) : S90 - S90
  • [49] PD-1 and PD-L1 in neoplastic cells and the tumor microenvironment of Merkel cell carcinoma
    Mitteldorf, Christina
    Berisha, Arbeneshe
    Tronnier, Michael
    Pfaltz, Monique C.
    Kempf, Werner
    JOURNAL OF CUTANEOUS PATHOLOGY, 2017, 44 (09) : 740 - 746
  • [50] Parameters of Tumor Microenvironment Determine Effectiveness of Anti-PD-1/PD-L1 Therapy
    Tashireva, Liubov A.
    Muravyova, Dariya T.
    Popova, Natalya O.
    Goldberg, Victor E.
    Vtorushin, Sergey V.
    Perelmuter, Vladimir M.
    BIOCHEMISTRY-MOSCOW, 2021, 86 (11) : 1461 - 1468
12345